Table 1 Clinicopathological characteristics of TRIM28 expression in GC patients

From: TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance

 

TRIM28 expression

P value

Number

Low

High

Age

  

0.280

 ≤60

83

170

 

 >60

60

153

 

Gender

  

0.274

 Female

47

90

 

 Male

96

233

 

Tumor location

  

0.198

 Lower

52

98

 

 Middle

31

62

 

 Upper

56

147

 

 Whole

1

0

 

Histology

  

0.176

 Adenocarcinoma

123

288

 

 SRCCa

20

31

 

Differentiation

  

0.624

 Poor

66

142

 

 Moderate

61

159

 

 Well

3

10

 

Tumor size

  

0.122

 <5 cm

85

173

 

 ≥5 cm

50

141

 

Vascular invasion

  

0.520

 Negative

71

149

 

 Positive

72

172

 

Lauren type

  

0.018

 Diffused

46

72

 

 Intestinal

70

175

 

 Mixed

20

73

 

pT stage

  

0.022

 1

19

19

 

 2

22

39

 

 3

72

199

 

 4

30

66

 

pN stage

  

0.003

 1

61

85

 

 2

24

60

 

 3

25

59

 

 4

33

118

 

pM stage

  

0.234

 0

132

291

 

 1

6

23

 

pTNM stage

  

0.018

 1

31

39

 

 2

48

99

 

 3

53

153

 

 4

6

23

 

cTNM stage

  

0.172

 1

27

36

 

 2

54

114

 

 3

48

114

 

 4

6

21

 
  1. aSRCC, signet-ring cell carcinoma
Back to article page